Reliance Secures Patent

Reliance's Strand Life Sciences has achieved a significant milestone with the grant of a landmark *Indian patent* for its blood-based early cancer detection technology. The key features of this technology include:
- Blood-based testing for early cancer detection
- Improved accuracy and reliability in diagnosis
- Potential to revolutionize the field of oncology. The granted patent further strengthens the company's intellectual property portfolio and marks a major breakthrough in the field of cancer detection and diagnosis.